- Home
- AEON vs QNME Comparison
AEON vs QNME Comparison
Compare AEON & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.25
N/A
Current Price
$0.54
Company Overview
Basic Information| Metric | AEON | QNME |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated Freight & Logistics |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 11.4M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AEON | QNME |
|---|---|---|
| Price | $0.25 | $0.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 9.4M | 707.2K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $18,315,155.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 42.28 |
| 52 Week Low | $0.18 | $0.26 |
| 52 Week High | $1.45 | $0.59 |
Technical Indicators
Market Signals| Indicator | AEON | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 71.58 |
| Support Level | $0.24 | $0.29 |
| Resistance Level | $0.33 | N/A |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 12.07 | 44.60 |
Price Performance
Historical Comparison AEON
QNME
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.